N-(1-(3-isopropyl-1,2,4-oxadiazol-5-yl)piperidin-4-yl)-6-(5-(methylsulfonyl)indolin-1-yl)-N-(trifluoromethyl)pyrimidin-4-amine

ID: ALA4869157

PubChem CID: 58074090

Max Phase: Preclinical

Molecular Formula: C24H28F3N7O3S

Molecular Weight: 551.60

Molecule Type: Unknown

Names and Identifiers

Canonical SMILES:  CC(C)c1noc(N2CCC(N(c3cc(N4CCc5cc(S(C)(=O)=O)ccc54)ncn3)C(F)(F)F)CC2)n1

Standard InChI:  InChI=1S/C24H28F3N7O3S/c1-15(2)22-30-23(37-31-22)32-9-7-17(8-10-32)34(24(25,26)27)21-13-20(28-14-29-21)33-11-6-16-12-18(38(3,35)36)4-5-19(16)33/h4-5,12-15,17H,6-11H2,1-3H3

Standard InChI Key:  KOHWFUOMWLTPDC-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 38 42  0  0  0  0  0  0  0  0999 V2000
    4.9403   -9.5174    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.1549   -8.7291    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    4.3649   -8.9374    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.3333   -7.8534    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9938   -9.2212    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7248   -7.9988    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6960   -9.6488    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7662   -8.4527    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.3838  -10.9014    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   14.9385   -7.1288    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.1058  -10.5029    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.2738   -9.3209    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.1514   -7.9599    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1241   -9.6791    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.3450  -11.2908    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   11.9078  -10.6897    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   11.8472   -9.2816    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0054   -8.3984    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.4358   -8.4259    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.5529   -9.7149    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.5899   -8.0661    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0199   -8.1010    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4184   -9.2516    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.1276   -7.2804    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.2953   -8.4958    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.8628   -8.4617    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.4652   -8.7144    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.6479   -7.3109    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2801   -9.6220    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.3771  -10.5880    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1794  -10.4330    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9818   -9.8727    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5389   -9.2798    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3036   -8.5029    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5116   -8.3178    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9553   -8.9157    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1935   -9.6902    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9188   -7.9518    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  2  0
 19  6  1  0
 23 14  1  0
 20 12  1  0
 17 26  1  0
 25 22  1  0
  4 13  1  0
 22  8  2  0
 23 19  2  0
 24 22  1  0
 10 24  1  0
 12 25  1  0
 11  9  1  0
 15 11  1  0
  7 23  1  0
 25 21  1  0
 11 16  1  0
  4 10  2  0
 17 20  1  0
  5  7  2  0
  8  4  1  0
 14 17  1  0
 18  5  1  0
  6 18  2  0
 21 26  1  0
 14 11  1  0
 13 27  1  0
 13 28  1  0
 29 33  1  0
 32 30  1  0
 30 31  1  0
 31 29  1  0
  5 29  1  0
 32 33  2  0
 33 34  1  0
 34 35  2  0
 35 36  1  0
 36 37  2  0
 37 32  1  0
 36  2  1  0
  2 38  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA4869157

   6-(5-methylsulfonyl-2,3-dihydroindol-1-yl)-N-[1-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)piperidin-4-yl]-N-(trifluoromethyl)pyrimidin-4-amine

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 551.60

Molecular Weight (Monoisotopic): 551.1926

AlogP: 4.08

#Rotatable Bonds: 6

Polar Surface Area: 108.56

Molecular Species: NEUTRAL

HBA: 10

HBD: ┄

#RO5 Violations: 1

HBA (Lipinski): 10

HBD (Lipinski): ┄

#RO5 Violations (Lipinski): 1

CX Acidic pKa: ┄

CX Basic pKa: 4.78

CX LogP: 5.85

CX LogD: 5.85

Aromatic Rings: 3

Heavy Atoms: 38

QED Weighted: 0.42

Np Likeness Score: -1.67

References

1. Kubo O, Takami K, Kamaura M, Watanabe K, Miyashita H, Abe S, Matsuda K, Tsujihata Y, Odani T, Iwasaki S, Kitazaki T, Murata T, Sato K..  (2021)  Discovery of a novel series of GPR119 agonists: Design, synthesis, and biological evaluation of N-(Piperidin-4-yl)-N-(trifluoromethyl)pyrimidin-4-amine derivatives.,  41  [PMID:34010766] [10.1016/j.bmc.2021.116208]

Source

Source(1):

• Scientific Literature